Related Experiment Videos
Trichoepithelioma: a 19-year clinicopathologic re-evaluation
M S Bettencourt1, V G Prieto, C R Shea
1Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.
Journal of Cutaneous Pathology
|November 7, 1999
Summary
Histopathologic features can differentiate trichoepithelioma (TE) from basal cell carcinoma (BCC). Key differences include retraction effect, stroma type, and papillary-mesenchymal bodies, aiding accurate diagnosis and predicting recurrence risk.
Area of Science:
- Dermatopathology
- Oncology
- Histology
Background:
- Accurate histopathologic distinction between trichoepithelioma (TE) and basal cell carcinoma (BCC) is clinically significant but often challenging.
- Misdiagnosis can lead to inappropriate treatment and affect patient outcomes.
Purpose of the Study:
- To evaluate histopathologic criteria for differentiating TE from BCC.
- To identify features that predict recurrence in these lesions.
Main Methods:
- Retrospective review of 73 histologically diagnosed trichoepithelioma cases.
- Analysis of nine histopathologic features: stroma, retraction effect, papillary-mesenchymal bodies (PMB), amyloid, mitotic figures, apoptotic cells, inflammation, granuloma, and calcification.
- Correlation of histopathologic findings with clinical data, including recurrence.
Main Results:
- Of 73 cases, 48 (65%) were confirmed TE, 15 (21%) were reclassified as basal cell carcinoma (RC-BCC), and 8 (11%) as other lesions.
- Retraction effect (100% RC-BCC vs. 37% TE), myxoid stroma (80% RC-BCC vs. 12% TE), and PMB (20% RC-BCC vs. 81% TE) were key differentiating features.
- Five of 15 RC-BCC cases recurred (33%), while no confirmed TE cases recurred.
Conclusions:
- A combination of histopathologic features, including retraction effect, stroma, and PMB, can reliably distinguish TE from BCC.
- Histopathologic assessment aids in predicting the recurrence potential of these skin lesions.